Status:
COMPLETED
Evaluation of the Effectiveness of Bian-Stone Therapy in Children With Autism Spectrum Disorder
Lead Sponsor:
Taichung Tzu Chi Hospital
Conditions:
Evaluation of Bian Stone Therapy for Autism Spectrum Disorder
Eligibility:
All Genders
18-6 years
Phase:
NA
Brief Summary
Autism spectrum disorder (ASD) is a pervasive developmental disorder of brain abnormalities. It presents with difficulties of communication and social interaction, and restrictive interests and restri...
Eligibility Criteria
Inclusion
- Diagnosed with Autism Spectrum Disorder (ASD) based on DSM-5 diagnostic criteria, and additionally screened using the T-STAT assessment tool, with severity categorized as mild or moderate.
- Patients aged between 1.5 and under 6 years, regardless of gender. 3.A Full-Scale IQ of 70 or above as measured by the Wechsler Intelligence Scale for Children (WISC).
- No prior experience with Bianshi therapy. 5.Consent obtained from the patient or their guardian to provide relevant clinical data for use in this study.
Exclusion
- Individuals who do not meet the aforementioned inclusion criteria. 2.Severe hearing, visual, or motor impairments, or diagnoses of cerebral palsy or epilepsy.
- Presence of other comorbid conditions, such as Tuberous Sclerosis, Fragile X Syndrome, Timothy Syndrome, male Rett Syndrome (with MECP2 gene mutation), and other chromosomal abnormalities (e.g., Angelman syndrome, Prader-Willi syndrome, Phelan-McDermid syndrome, and other related syndromes).
- Use of dietary supplements or health products.
Key Trial Info
Start Date :
April 28 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 28 2025
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT06998459
Start Date
April 28 2025
End Date
April 28 2025
Last Update
May 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Taichung, Taiwan, 427